Nafamostat Mesilate as an Anti-Coagulant during Paediatric ECMO. Its Preventive Effect against Cranial Bleeding of Neonates and Infants.
Nafamostat Mesilate as an Anti-Coagulant during Paediatric ECMO. Its Preventive Effect against Cranial Bleeding of Neonates and Infants.
复制标题
甲磺酸萘莫司他作为儿科 ECMO 期间的抗凝剂。
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
M.D.
中科院分区：
文献类型：
--
作者：
Naoki Shimizu;M.D.;Ph.D.;Luis Akiyama;M.D.; Osamu Saito;M.D.;Takayuki Sueishi;M.D.
